Q2 2026 Earnings Call Transcript January 6, 2026 AngioDynamics, Inc. misses on earnings expectations. Reported EPS is ...
Midline catheters and vascular access devices (VADs) play a pivotal role in modern clinical practice by offering less invasive alternatives to central venous access. Midline catheters, which are ...
Zacks.com on MSN
ANGO Stock Dips Despite Q2 Earnings Beat, Gross Margin Improves
AngioDynamics reports flat Q2 earnings while revenue increase 8.8% and gross margin expands 170 bps on stronger Med Tech ...
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, ...
Rest vs. Revenge: Should the Lions Play Their Starters? The debate surrounding Detroit’s approach to this game is fueled by playoff implications. If the Minnesota Vikings win their game on Sunday, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback